Skip to content
DataLookout
Menu

NCT07768306

Evaluation of Safety, Pharmacokinetics, Distribution,Radiation Safety and Sensitivity/Specificity of PET/CT Imaging With 68Ga-NYM096 in Participants With IRM

StatusRecruiting
PhasePhase 1
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Recruitment opened Show 4 more changesShow less
    • Eligibility criteria expanded, about 15 words
    • Study sites: 0 to 1
    • Start date changed from estimate of Sep 2026 to Nov 8, 2026
    • Study description revised
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Incidence of Treatment-Emergent Adverse events [Safety and Tolerability]
Timeframe: 4 days

Arms and interventions

⁶⁸Ga-NYM096 InjectionExperimental

Drugs: 68Ga-NYM096 injection

Sites

1 site in 1 country

  • Peking Union Medical College HospitalBeijing, China